Intarcia announces two presentations at 50th EASD meeting

Intarcia Therapeutics, Inc. announced its participation in the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place in Vienna September 15 -19.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Industry News Diabetes GLP-1 therapy ITCA 650 Latest News subcutaneous osmotic pump type 2 diabetes Source Type: news